Limin Chen

Chinese Academy of Medical Sciences, China


Limin Chen received his Medical degree from Luzhou Medical College, China, and Ph.D. degree in molecular genetics from the University of Toronto, Toronto, Canada. He finished his postdoctoral training at Merck Research Labs, Merck & Co. Inc. (West Point, PA) and Harvard Medical School, Boston, USA. Chen, a Professor with Chinese Academy of Medical Sciences (CAMS) /Peking Union Medical College (PUMC) and also an Affiliated Scientist with the University of Toronto, now is the Director and Chief Scientific Officer of the Center for Transfusion Transmitted Diseases, IBT, CAMS/PUMC, and Member of the American Association for the Studies of Liver Diseases (AASLD) and Canadian Association for the Studies of Liver (CASL). He is one of the leading experts in studying the role of host factors in HCV resistance to interferon therapy. His pioneering work in the identification of the 18-hepatic gene response signature used to predict treatment response and the role of endogenous type-I interferon system in treatment failure of HCV infection has gained wide acceptance with over 350 citations. Dr. Chen serves as Associate Editor for two scientific journals and as editorial board member for 11 journals. He is an Invited Reviewer for journals such as Gastroenterology, Hepatology, Gut, Journal of Hepatology, and many others.

Biography Updated on 21 September 2014

Scholarly Contributions [Data Provided by ]